Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 12:47:55 28/02/2017 HKT 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.69M 2.48M 2.3M 4.35M 294M 4.43M 29.69M 11.66M 145M 11.56M 11.31M 497M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.17M 2.93M 2.7M 5.13M 346M 5.22M 34.98M 13.74M 170M 13.62M 13.33M 586M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+0.58%+3.79%+4.16%+11.62% 50.44B
-2.22%-1.64%+385.40%+586.81% 40.63B
-0.54%+0.91%+25.57%-5.28% 34.88B
-1.36%-3.48%+17.88%+55.14% 33.67B
+1.21%-0.79%+4.46%+35.18% 26.29B
-1.81%+0.94% - - 17.11B
+0.51%-4.75%+63.97%+122.60% 15.29B
-9.37%-29.97%+37.45%+39.42% 10.62B
+0.23%-0.26%+15.51%+21.54% 13.74B
Average +8.83%+8.09%+69.30%+108.38% 24.27B
Weighted average by Cap. -0.70%-0.03%+84.54%+131.30%

Financials

2017 2018
Net sales 16.01K 14K 12.92K 11.93K 22.64K 1.53M 23.02K 154K 60.61K 752K 60.11K 58.8K 2.59M 124 108.46 100.04 92.4 175.33 11.83K 178.27 1.2K 469.41 5.83K 465.58 455.45 20.03K
Net income -481K -421K -388K -358K -680K -45.87M -691K -4.64M -1.82M -22.6M -1.81M -1.77M -77.68M -976K -853K -787K -727K -1.38M -93.04M -1.4M -9.4M -3.69M -45.84M -3.66M -3.58M -158M
Net Debt 497K 434K 401K 370K 702K 47.38M 714K 4.79M 1.88M 23.34M 1.87M 1.82M 80.23M 548K 480K 442K 409K 775K 52.3M 788K 5.29M 2.08M 25.76M 2.06M 2.01M 88.57M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-